CinCor Pharma, Inc.
CINC · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $137 | $26 | $11 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $0 | $0 |
| Total Curr. Assets | $141 | $27 | $12 |
| Property Plant & Equip (Net) | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $141 | $27 | $12 |
| Liabilities | – | – | – |
| Payables | $1 | $4 | $1 |
| Short-Term Debt | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $3 | $1 |
| Total Curr. Liab. | $17 | $7 | $2 |
| LT Debt | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 |
| Total NC Liab. | $188 | $47 | $15 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 |
| Total Liabilities | $205 | $54 | $17 |
| Equity | – | – | – |
| Pref Stock | $47 | $0 | $0 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$78 | -$27 | -$5 |
| AOCI | -$47 | $0 | $0 |
| Other Equity | $61 | $0 | $0 |
| Total Equity | -$64 | -$27 | -$5 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $141 | $27 | $12 |
| Net Debt | -$137 | -$26 | -$11 |